| 商品CAS |
貨號 |
商品名稱 |
品牌 |
規格型號 |
標準價 |
成交價 |
包裝 |
庫存與貨期 |
購 買 |
|
618413-75-5
|
S33350-100mg |
WAY-639012-WAY-639012 |
MedMol |
98% |
￥3900.00 |
請登錄 |
100mg |
0
|
 |
|
2411429-33-7
|
S33291-100mg |
NCT-58- |
MedMol |
98% |
￥13800.00 |
請登錄 |
100mg |
0
|
|
|
1399177-37-7
|
S29766-5mg |
TVB-2640-TVB-2640 |
MedMol |
97% |
￥960.00 |
請登錄 |
5mg |
10
|
|
|
1399177-37-7
|
S29766-25mg |
TVB-2640-TVB-2640 |
MedMol |
97% |
￥2400.00 |
請登錄 |
25mg |
7
|
|
|
879127-07-8
|
S29705-1mg |
EGFR inhibitor-EGFR inhibitor |
MedMol |
98% |
￥270.00 |
請登錄 |
1mg |
9
|
|
|
879127-07-8
|
S29705-25mg |
EGFR inhibitor-EGFR inhibitor |
MedMol |
98% |
￥3040 |
請登錄 |
25mg |
0
|
|
|
667463-85-6
|
S29700-25mg |
BIO-acetoxime-BIO-acetoxime (Synonyms:) |
MedMol |
98% |
￥410.00 |
請登錄 |
25mg |
6
|
|
|
211555-08-7
|
S29699-5mg |
WHI-P180-WHI-P180 |
MedMol |
98% |
￥595.00 |
請登錄 |
5mg |
6
|
|
|
879127-16-9
|
S29696-5mg |
Aurora Kinase Inhibitor III-N-(3-((4-((3-(trifluoromethyl)phenyl)amino)pyrimidin-2-yl)amino)phenyl)cyclopropanecarboxamide |
MedMol |
98% |
￥115.00 |
請登錄 |
5mg |
9
|
|
|
879127-16-9
|
S29696-100mg |
Aurora Kinase Inhibitor III-N-(3-((4-((3-(trifluoromethyl)phenyl)amino)pyrimidin-2-yl)amino)phenyl)cyclopropanecarboxamide |
MedMol |
98% |
￥1200.00 |
請登錄 |
100mg |
0
|
|
|
1392116-14-1
|
S29693-5mg |
JD-5037-(S)-2-(((E)-((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)((4-chlorophenyl)sulfonamido)methylene)amino)-3-methylbutanamide |
MedMol |
98% |
￥560.00 |
請登錄 |
5mg |
5
|
|
|
1392116-14-1
|
S29693-25mg |
JD-5037-(S)-2-(((E)-((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)((4-chlorophenyl)sulfonamido)methylene)amino)-3-methylbutanamide |
MedMol |
98% |
￥1600.00 |
請登錄 |
25mg |
6
|
|
|
1392116-14-1
|
S29693-100mg |
JD-5037-(S)-2-(((E)-((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)((4-chlorophenyl)sulfonamido)methylene)amino)-3-methylbutanamide |
MedMol |
98% |
￥4800.00 |
請登錄 |
100mg |
0
|
|
|
209808-47-9
|
S29691-5mg |
ARM390 HCl-N,N-Diethyl-4-(phenyl-4-piperidinylidenemethyl)benzamide Hydrochloride |
MedMol |
98% |
￥650.00 |
請登錄 |
5mg |
7
|
|
|
209808-47-9
|
S29691-25mg |
ARM390 HCl-N,N-Diethyl-4-(phenyl-4-piperidinylidenemethyl)benzamide Hydrochloride |
MedMol |
98% |
￥2000.00 |
請登錄 |
25mg |
6
|
|
|
917837-54-8
|
S28564-5mg |
CCMI-[N-(4-Chlorophenyl)]-α-[(4-chlorophenyl)-aminomethylene]-3-methyl-5-isoxazoleacetamide |
MedMol |
98% |
￥224.00 |
請登錄 |
5mg |
10
|
|
|
917837-54-8
|
S28564-25mg |
CCMI-[N-(4-Chlorophenyl)]-α-[(4-chlorophenyl)-aminomethylene]-3-methyl-5-isoxazoleacetamide |
MedMol |
98% |
￥722.50 |
請登錄 |
25mg |
7
|
|
|
875320-31-3
|
S28117-5mg |
JNJ26481585-Quisinostat (JNJ-26481585) 2HCl |
MedMol |
98% |
￥500.00 |
請登錄 |
5mg |
10
|
|
|
875320-31-3
|
S28117-25mg |
JNJ26481585-Quisinostat (JNJ-26481585) 2HCl |
MedMol |
98% |
￥1500.00 |
請登錄 |
25mg |
5
|
|
|
1225497-78-8
|
S28098-5mg |
Rigosertib (ON-01910)-sodium (E)-2-((2-methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)phenyl)amino)acetate |
MedMol |
95% |
￥160.00 |
請登錄 |
5mg |
4
|
|